[Pharmacological effects on the complement system. Possibilities and limitations of anti-inflammatory therapy].
Kirschfink
M
M
Institut für Immunologie, Universität Heidelberg.
D000706:Anaphylatoxins / Q000502:physiology; D000818:Animals; D003167:Complement Activation / Q000187:drug effects; D003169:Complement Inactivator Proteins / Q000494:pharmacology*; D003165:Complement System Proteins / Q000187:drug effects* / Q000276:immunology / Q000502:physiology; D005938:Glucocorticoids / Q000494:pharmacology; D006084:Graft Rejection / Q000276:immunology; D006168:Guinea Pigs; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D007136:Immunoglobulins / Q000494:pharmacology; D007249:Inflammation / Q000276:immunology / Q000628:therapy*; D011323:Primates; D011951:Receptors, Complement / Q000187:drug effects / Q000502:physiology; D012772:Shock, Septic / Q000276:immunology / Q000628:therapy; D013552:Swine
D000706:Anaphylatoxins; D003169:Complement Inactivator Proteins; D005938:Glucocorticoids; D007136:Immunoglobulins; D011951:Receptors, Complement; D006493:Heparin; D003165:Complement System Proteins
Pharmakologische Beeinflussung des Komplementsystems. Möglichkeiten und Grenzen einer antiphlogistischen Therapie.